MAKING HEARING A PRIORITY
CILcare is the world’s leading R&D services company committed to making hearing a priority. Take an in-depth look at how we can support your R&D program to prevent and treat ear disorders.
Discover our services
Please meet Marie-Pierre Pasdelou, PhD., CILcare Inc Director and Michael Naimark, Director of Business Development CBSET, to learn more about their article in stem cell and regenerative therapies for hearing loss:...
CILcare will be attending the Biotech Outsourcing Strategies Event 2018 taking place in Basel Meet Wahid AWAD, Ph.D. and attend his presentation on June 19th, 2018 from 11 to 12 AM to discover the topic: "assessing compound efficacy in an age-related hearing loss...
The pitch of CILcare's CEO Celia Belline at BIO International Convention 2018 discusses the development of new treatments for hearing disorders. Due to the significant increase in hearing loss, specifically in the younger population, hearing has become a real public...
Pharma / Biotech
Develop new therapies. Repurpose existing drugs in otology.
Innovate with drug delivery devices for the inner ear. Speed up market access of hearing aids.
Develop health food ingredients for the prevention of hearing loss, tinnitus, or otitis.
Improve and develop products to treat ear inflammation in pets.
CILcare, the world leading CRO dedicating to ear disorders
CILcare is a unique R&D services company specialized in ear disorders. We offer preclinical services and consultancy to accelerate the development of innovative products for hearing loss, tinnitus, and otic disorders.